Martin J O'Connell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martin J O'Connell has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Cradock
Radiography and Diagnostic Imaging, School of Medicine, University College Dublin, Health Sciences Centre Belfield, Dublin 4, Ireland
1 shared publication - Ciara McEntee
Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
1 shared publication - Emma Stanley
Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
1 shared publication - James Bisset
Department of Radiology, Mater Private Hospital, Dublin, Ireland
1 shared publication - Jonathan P. McNulty
Radiography and Diagnostic Imaging, School of Medicine, University College Dublin, Ireland
1 shared publication - Maria Michele Byrne
Department of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin, Ireland
1 shared publication
Latest Publications
- Open Access
- 28 April 2017
- Published by Springer Nature in EJNMMI Research
- Vol. 7 (1) , 1-8
Carotid atherosclerotic plaques standardised uptake values: software challenges and reproducibility
Positron emission tomography–computed tomography (PET-CT) carotid standardised uptake values (SUV) of 18F-fluorodeoxyglucose (18FDG) have been proposed as an inflammatory biomarker for determining cerebrovascular diseases such as stroke. Consideration of varying methodological approaches and software packages is critical to the calculation of accurate SUVs in cross-sectional and longitudinal patient studies. The aim of this study was to investigate whether or not carotid atherosclerotic plaque SUVs are consistent and reproducible between software packages. 18FDG-PET SUVs of carotids were taken in 101 patients using two different software packages. Quality assurance checks were performed to standardise techniques before commencing the analysis where data from five to seven anatomical sites were measured. A total of ten regions of interest were drawn on each site analysed. Statistical analyses were then performed to compare SUV measurements from the two software packages and to explore reproducibility of measurements. Lastly, the time taken to complete each analysis was measured and compared. Statistically significant differences in SUV measurements, between the two software packages, ranging from 9 to 21.8% were found depending on ROI location. In 79% (n = 23) of the ROI locations, the differences between the SUV measurements from each software package were found to be statistically significant. The time taken to perform the analyses and export data from the software packages also varied considerably. This study highlights the importance of standardising all aspects of methodological approaches to ensure accuracy and reproducibility. Physicians must be aware that when a PET-CT data set is analysed, subsequent follow-ups must be verified, if possible, with the same software package or cross-calibration between packages should be performed.
- 28 April 2017
- Published by Springer Nature in EJNMMI Research
- Vol. 7 (1) , 1-8
Open AccessCarotid atherosclerotic plaques standardised uptake values: software challenges and reproducibility
Positron emission tomography–computed tomography (PET-CT) carotid standardised uptake values (SUV) of 18F-fluorodeoxyglucose (18FDG) have been proposed as an inflammatory biomarker for determining cerebrovascular diseases such as stroke. Consideration of varying methodological approaches and software packages is critical to the calculation of accurate SUVs in cross-sectional and longitudinal patient studies. The aim of this study was to investigate whether or not carotid atherosclerotic plaque SUVs are consistent and reproducible between software packages. 18FDG-PET SUVs of carotids were taken in 101 patients using two different software packages. Quality assurance checks were performed to standardise techniques before commencing the analysis where data from five to seven anatomical sites were measured. A total of ten regions of interest were drawn on each site analysed. Statistical analyses were then performed to compare SUV measurements from the two software packages and to explore reproducibility of measurements. Lastly, the time taken to complete each analysis was measured and compared. Statistically significant differences in SUV measurements, between the two software packages, ranging from 9 to 21.8% were found depending on ROI location. In 79% (n = 23) of the ROI locations, the differences between the SUV measurements from each software package were found to be statistically significant. The time taken to perform the analyses and export data from the software packages also varied considerably. This study highlights the importance of standardising all aspects of methodological approaches to ensure accuracy and reproducibility. Physicians must be aware that when a PET-CT data set is analysed, subsequent follow-ups must be verified, if possible, with the same software package or cross-calibration between packages should be performed.
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160389
Impact of sensory design interventions on image quality, patient anxiety and overall patient experience at MRI
This study aimed to assess the effect of sensory stimulation on patient MRI experience and to assess whether sensory stimulation has a significant effect on MR image quality. A case-control study was conducted over 4 months, involving patients undergoing MRI brain, cervical spine, breast and prostate. The study involved 106 patients, 64 cases and 42 controls. Cases underwent sensory stimulation during the scan in the form of a scented cotton pad placed in the scanner near their head and/or calming bird noises were played over headphones. Post-scan, participants completed a questionnaire regarding their experience of MRI. Scanning radiographers completed a questionnaire regarding patient tolerance of the scan. All studies were evaluated by two radiologists for the presence of movement artefact. 39% of cases and 38% of controls reported anxiety in the days preceding MRI. 6.2% of cases required coaching during image acquisition, while 9.7% of controls required coaching. 4.7% of cases and 4.8% controls required sequence repetition owing to movement artefact. Mean patient experience score (as graded by the patient) for controls was 1.74 ± 0.63 standard deviation (SD) and for cases, it was 1.67 ± 0.60 SD. (Lower assigned scores equated to a better experience). Mean patient experience score based on comments on a 5-point scale as graded by two observers was 2.81 ± 0.70 SD for controls, 2.42 + 0.94 SD for sound intervention and 2.46 ± 1.01 SD for scent intervention. Mean motion artefact score graded by the two radiologists was 1.13 ± 0.53 SD for controls and 1.08 ± 0.36 SD for cases. (A lower score equated to less movement artefact). We demonstrated a trend towards a relaxing experience in those patients undergoing MRI for the first time who underwent sensory intervention. Participant positive ratings of the smell pleasantness were associated with a reduced likelihood of experiencing anxiety (p = 0.13). Results were not statistically significant. This study demonstrated a subjectively improved experience of MRI for some patients with the intervention of sound and smell. The study failed to show a significant decrease in patient movement during MRI investigations. This may relate to the small study size and a low level of patient movement in the case group. Sound and olfactory sensory environment interventions at MRI can improve the patient experience. These low-cost interventions are well tolerated, may improve acceptance of MRI in patients with anxiety and offer a competitive advantage to imaging centres.
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160389
Impact of sensory design interventions on image quality, patient anxiety and overall patient experience at MRI
This study aimed to assess the effect of sensory stimulation on patient MRI experience and to assess whether sensory stimulation has a significant effect on MR image quality. A case-control study was conducted over 4 months, involving patients undergoing MRI brain, cervical spine, breast and prostate. The study involved 106 patients, 64 cases and 42 controls. Cases underwent sensory stimulation during the scan in the form of a scented cotton pad placed in the scanner near their head and/or calming bird noises were played over headphones. Post-scan, participants completed a questionnaire regarding their experience of MRI. Scanning radiographers completed a questionnaire regarding patient tolerance of the scan. All studies were evaluated by two radiologists for the presence of movement artefact. 39% of cases and 38% of controls reported anxiety in the days preceding MRI. 6.2% of cases required coaching during image acquisition, while 9.7% of controls required coaching. 4.7% of cases and 4.8% controls required sequence repetition owing to movement artefact. Mean patient experience score (as graded by the patient) for controls was 1.74 ± 0.63 standard deviation (SD) and for cases, it was 1.67 ± 0.60 SD. (Lower assigned scores equated to a better experience). Mean patient experience score based on comments on a 5-point scale as graded by two observers was 2.81 ± 0.70 SD for controls, 2.42 + 0.94 SD for sound intervention and 2.46 ± 1.01 SD for scent intervention. Mean motion artefact score graded by the two radiologists was 1.13 ± 0.53 SD for controls and 1.08 ± 0.36 SD for cases. (A lower score equated to less movement artefact). We demonstrated a trend towards a relaxing experience in those patients undergoing MRI for the first time who underwent sensory intervention. Participant positive ratings of the smell pleasantness were associated with a reduced likelihood of experiencing anxiety (p = 0.13). Results were not statistically significant. This study demonstrated a subjectively improved experience of MRI for some patients with the intervention of sound and smell. The study failed to show a significant decrease in patient movement during MRI investigations. This may relate to the small study size and a low level of patient movement in the case group. Sound and olfactory sensory environment interventions at MRI can improve the patient experience. These low-cost interventions are well tolerated, may improve acceptance of MRI in patients with anxiety and offer a competitive advantage to imaging centres.
- Open Access
- 19 October 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 286
Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report
We report the case of a giant intrathyroidal parathyroid adenoma weighing 59 g in a young woman presenting acutely with severe hypercalcemia requiring correction and adequate preoperative management prior to surgery. Parathyroid adenomas account for 85 % of cases of primary hyperparathyroidism. Those weighing more than 3.5g are classified as giant parathyroid adenomas. There are only 25 cases of parathyroid adenomas weighing over 30g reported in the literature. With the wide availability of biochemical screening tests in Western countries, mildly elevated calcium levels are often discovered incidentally. Our case is unusual for the extreme level of hypercalcemia, the patient’s young age, and the weight of the adenoma, particularly in a developed country. A 21-year-old Irish woman presented with a 3-week history of an enlarging right-sided neck mass. There was no dysphagia, stridor, or symptoms of hyperthyroidism or hypercalcemia. On examination, there was a firm painless swelling in the right lobe of her thyroid. Her thyroid function tests were normal. Corrected serum calcium was markedly elevated at 3.96 mmol/L with hypophosphatemia of 0.35 mmol/L. She was treated with bisphosphonates and fluids administered intravenously. Her parathyroid hormone level was over 20 times the upper limit of normal. Ultrasound revealed a solid and cystic nodule in the lower pole of the right lobe of her thyroid. Parathyroid scintigraphy demonstrated a 5×4 cm lesion which concentrated tracer. A right-sided parathyroidectomy, right thyroid lobectomy, and level VI neck dissection were performed. An encapsulated multiloculated solid cystic mass weighing 59 g was removed. There was no definite infiltration of the capsule and MIB1 count was low at 1 % thus the specimen lacked the diagnostic features of carcinoma. On the third postoperative day, hungry bone syndrome developed and calcium replacement administered intravenously was required. At 1-year postoperative, she was weaned off calcium and alfacalcidol. A follow-up ultrasound showed unremarkable residual thyroid. Any patient with an isolated hypercalcemia warrants a thorough work-up. Hungry bone syndrome is a potentially avoidable condition; thus the clinician should be highly attuned to the risk of hungry bone syndrome post-parathyroidectomy, which correlates with the weight of the adenoma resected.
- 19 October 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 286
Open AccessAcute presentation of a giant intrathyroidal parathyroid adenoma: a case report
We report the case of a giant intrathyroidal parathyroid adenoma weighing 59 g in a young woman presenting acutely with severe hypercalcemia requiring correction and adequate preoperative management prior to surgery. Parathyroid adenomas account for 85 % of cases of primary hyperparathyroidism. Those weighing more than 3.5g are classified as giant parathyroid adenomas. There are only 25 cases of parathyroid adenomas weighing over 30g reported in the literature. With the wide availability of biochemical screening tests in Western countries, mildly elevated calcium levels are often discovered incidentally. Our case is unusual for the extreme level of hypercalcemia, the patient’s young age, and the weight of the adenoma, particularly in a developed country. A 21-year-old Irish woman presented with a 3-week history of an enlarging right-sided neck mass. There was no dysphagia, stridor, or symptoms of hyperthyroidism or hypercalcemia. On examination, there was a firm painless swelling in the right lobe of her thyroid. Her thyroid function tests were normal. Corrected serum calcium was markedly elevated at 3.96 mmol/L with hypophosphatemia of 0.35 mmol/L. She was treated with bisphosphonates and fluids administered intravenously. Her parathyroid hormone level was over 20 times the upper limit of normal. Ultrasound revealed a solid and cystic nodule in the lower pole of the right lobe of her thyroid. Parathyroid scintigraphy demonstrated a 5×4 cm lesion which concentrated tracer. A right-sided parathyroidectomy, right thyroid lobectomy, and level VI neck dissection were performed. An encapsulated multiloculated solid cystic mass weighing 59 g was removed. There was no definite infiltration of the capsule and MIB1 count was low at 1 % thus the specimen lacked the diagnostic features of carcinoma. On the third postoperative day, hungry bone syndrome developed and calcium replacement administered intravenously was required. At 1-year postoperative, she was weaned off calcium and alfacalcidol. A follow-up ultrasound showed unremarkable residual thyroid. Any patient with an isolated hypercalcemia warrants a thorough work-up. Hungry bone syndrome is a potentially avoidable condition; thus the clinician should be highly attuned to the risk of hungry bone syndrome post-parathyroidectomy, which correlates with the weight of the adenoma resected.